0001622964-17-000001.txt : 20170628 0001622964-17-000001.hdr.sgml : 20170628 20170628122748 ACCESSION NUMBER: 0001622964-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170628 DATE AS OF CHANGE: 20170628 EFFECTIVENESS DATE: 20170628 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Syntimmune, Inc. CENTRAL INDEX KEY: 0001622964 IRS NUMBER: 464167490 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-289606 FILM NUMBER: 17934504 BUSINESS ADDRESS: STREET 1: 257 PARK AVENUE SOUTH STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 212-498-0011 EXT 301 MAIL ADDRESS: STREET 1: 257 PARK AVENUE SOUTH STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 D 1 primary_doc.xml X0707 D LIVE 0001622964 Syntimmune, Inc. 257 PARK AVENUE SOUTH 15TH FLOOR NEW YORK NY NEW YORK 10010 212-498-0011 EXT 301 DELAWARE None None Corporation true 2013 Laurence Blumberg, M.D. 257 Park Avenue South 15th Floor NEW YORK NY NEW YORK 10010 Executive Officer Director David De Graaf, Ph.D. 257 Park Avenue South 15th Floor NEW YORK NY NEW YORK 10010 Executive Officer Director Sam Hall, Ph.D. 257 Park Avenue South 15th Floor NEW YORK NY NEW YORK 10010 Director Seth Harrison, M.D. 257 Park Avenue South 15th Floor NEW YORK NY NEW YORK 10010 Director Richard Blumberg, M.D. 257 Park Avenue South 15th Floor NEW YORK NY NEW YORK 10010 Director Burt Adelman, M.D. 257 Park Avenue South 15th Floor NEW YORK NY NEW YORK 10010 Director Aaron Kantoff 257 Park Avenue South 15th Floor NEW YORK NY NEW YORK 10010 Director Biotechnology Decline to Disclose 06b false 2017-06-19 false true false 0 49999991 17999998 31999993 false 3 0 0 0 false Syntimmune, Inc. /s/ David De Graaf, Ph.D. David De Graaf, Ph.D. CEO 2017-06-28